A pharmaceutical company headquartered in New Jersey is shrinking its workforce one month after pulling a drug from the market over public health concerns raised by the Food and Drug Administration.
Intercept Pharmaceuticals, based in Morristown, is laying off 146 employees, according to a Worker Adjustment and Retraining Notification filing with the state.
